Cargando…
Tumor Budding as a Marker for Poor Prognosis and Epithelial–Mesenchymal Transition in Lung Cancer: A Systematic Review and Meta-Analysis
INTRODUCTION: Currently, tumor budding (TB) is considered to predict the prognosis of patients. The prognostic significance of TB has also been explored in patients with lung cancer, but has not been fully clarified. In the present meta-analysis, we evaluated the prognostic significance, clinicopath...
Autores principales: | Thakur, Nishant, Ailia, Muhammad Joan, Chong, Yosep, Shin, Ok Ran, Yim, Kwangil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201279/ https://www.ncbi.nlm.nih.gov/pubmed/35719992 http://dx.doi.org/10.3389/fonc.2022.828999 |
Ejemplares similares
-
Tumor Budding in Gynecologic Cancer as a Marker for Poor Survival: A Systematic Review and Meta-Analysis of the Perspectives of Epithelial–Mesenchymal Transition
por: Ailia, Muhammad Joan, et al.
Publicado: (2022) -
Current Trend of Artificial Intelligence Patents in Digital Pathology: A Systematic Evaluation of the Patent Landscape
por: Ailia, Muhammad Joan, et al.
Publicado: (2022) -
High Poly(ADP-Ribose) Polymerase Expression Does Relate to Poor Survival in Solid Cancers: A Systematic Review and Meta-Analysis
por: Thakur, Nishant, et al.
Publicado: (2021) -
Calculated Tumor-Associated Neutrophils Are Associated with the Tumor—Stroma Ratio and Predict a Poor Prognosis in Advanced Gastric Cancer
por: Kim, Eun Young, et al.
Publicado: (2022) -
Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker
por: Chong, Yosep, et al.
Publicado: (2020)